Tags: Life Sciences
Changes in the law on marketing of veterinary medicines: what you need to know
Belgium is welcoming a significant development in the field of veterinary medicine law. The Act of 11 July 2023 containing various provisions on health, which entered into force on 8 September 2023, introduces changes across a wide spectrum of healthcare domains, which are encompassed in approximately 20 chapters.
EU Court of Justice: Parallel importer may not remove PPP batch number
This blog post mainly focuses on the CJEU’s findings regarding the responsibility of parallel importers for ensuring the display of the original batch number on the product packaging.
Three changes in Belgian food law in 2023
In this short article, our food law experts look at two developments in Belgian food law that have taken place in 2023.
The 5 major changes in Belgian pharma law of 2023
In this article, our pharma law experts look back and discuss five noteworthy developments in Belgian pharma law.
Belgium aims for hospitals to increase their biosimilars uptake
Despite many initiatives by the (former) Minister of Health, the uptake of biosimilars in Belgium has remained rather low. In this blog, we summarise the new rules, which apply since 2 October 2023.
The Belgian Competition Authority publishes a specific analytical framework for hospital concentrations
This article is an updated version of our previous article on the uncertainty regarding hospital merger control, focusing on the BCA’s decision of 28 June 2023.
WEBINAR VIDEO | Navigating Mergers and Acquisitions in Life Sciences: Insights for Success and Pitfalls to avoid
During this webinar, the experts from our assembled transactions team, Richard Liu, Mieke D’hanis and Pauline Geentjens, provide valuable insights, inform you of common pitfalls and let you in on a number of tips and tricks during an Mergers and Acquisitions process.
New product liability regime on the way
The European Commission published a draft proposal for a revised Product Liability Directive (the “PLD Proposal”) on 28 September 2022, which aims to bring the European Union’s product liability regime ‘up to speed’ with the digital age, circular economy business models and global value chains.
Navigating Mergers and Acquisitions in Life Sciences: Insights for Success and Pitfalls to avoid
The experts from our assembled transactions team will provide valuable insights, inform you of common pitfalls and let you in on a number of tips and tricks during an M&A process.
Kirian Claeyé promoted to partner at ALTIUS
ALTIUS is delighted to announce that Kirian Claeyé has been promoted to partner as per September 2023. Congratulations Kirian!
The Belgian Competition Authority has declared itself competent to examine mergers and acquisitions between hospitals under its merger control regime, following the Act of 29 March 2021
A lot of uncertainty has existed about the requirement for hospitals to notify M&A transactions to the Belgian Competition Authority (“BCA”). On 28 June 2023, the BCA decided to partially lift the stand-still obligation regarding a concentration between two hospitals, and it further clarified the applicable rules in a follow-up Communication of 14 July 2023.
WEBINAR VIDEO | The New EU Deforestation Regulation: Stay Compliant, Succeed Sustainably
In this Life Sciences session, the experts from our agri-food law team Philippe de Jong and Bart Junior Bollen provided valuable insights into the Regulation’s implications and equiped businesses with the necessary knowledge to ensure compliance in this evolving landscape.